$1.62
0.01 (+0.62%)
Labopharm, Inc. (DDSS)
CAPS Rating:
An international, specialty pharmaceutical company focused on improving existing drugs by incorporating its proprietary, advanced controlled-release technologies.

RSS Headlines
Fool UK
Recs
Drug delivery and reformulation is a crowded sector and requires branded life cycle extensions for strategies to be profitable
Great call! It's got to be a nice feeling when you're the only one in the entire CAPS universe that picks an underperformer (supported with a pitch). Kudos to you...hope you had it shorted in real life!
Nice timing :).
thanks for the kind comments but my "pitch" comes from being a VC on the left coast and watching various life science sectors. I've avoided loosing a LOT because of street level experiences in the trenches.Can't learn what I've learned in ANY MBA program.
Can't argue with the call but I can't understand your pitch. I doubt any of those other guys did either.